An event aimed at raising awareness of the most common cause of sight loss will be held in St Andrews. The Macular Society is ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...

Bayer submitted an application to the European Medicines Agency (EMA) to expand treatment intervals of up to 6 months with Eylea™ 8 mg (aflibercept 8 mg, ...

Metro spoke to nine couples who have been together for decades — from 15 years to 75 — to share their biggest relationship ...

Australia has become the first country outside of the United States to approve the use of the drug pegcetacoplan (SYFOVRE) to ...

Jay Mikosch adopted his dog, Murphy, from a local animal shelter. Murphy had ended up at the shelter because his previous owner needed to move into a senior living community ...

A sight loss organisation’s services in Scotland have been awarded a cash boost of nearly £100,000 for the next three years.

Roche’s Susvimo receives US FDA approval for the treatment of diabetic macular edema: Basel Thursday, February 6, 2025, 11:00 Hrs [IST] Roche announced that the US Food and Drug ...

"I am excited to offer Susvimo to my patients living with diabetic macular edema who want an option with longer intervals ...

The U.S. Food and Drug Administration (FDA) has approved ranibizumab injection (Susvimo, 100 mg/mL; Genentech) for the ...

The goal is to educate the public and professionals about AMD and support patients and families affected by vision impairment ...